Treatment of Chronic Pelvic Pain Syndrome with Persistent or Recurrent Urinary Bladder Pain and Urinary Frequency
This protocol covers the structured first-line management of chronic pelvic pain syndrome when it presents as persistent or recurrent pain in the urinary bladder region, accompanied by increased urinary frequency or pain that worsens with bladder filling, with no infectious or structural cause identified.
Clinical Scenario
The pattern of concern is persistent or recurrent pain perceived in the urinary bladder region, present for at least three months, with at least one accompanying symptom — such as pain worsening with bladder filling, increased daytime urinary frequency, or night-time urinary frequency. No proven infection or other obvious local pathology is present. This presentation is consistent with primary bladder pain syndrome.
First-Line Approach (Overview)
Management combines an oral agent (amitriptyline) with oral pentosane polysulphate and structured dietary advice — the complete regimen, including titration guidance and the pathway for patients with a suboptimal response, is detailed in the full protocol.
Treatment Goals
- Reduction in urinary bladder pain severity
- Reduction in urinary frequency
- Response assessed at approximately six weeks
References
- Primary bladder pain syndrome is the occurrence of persistent or recurrent pain perceived in the urinary bladder region, accompanied by at least one other symptom, such as pain worsening with bladder filling and daytime and/or night-time urinary frequency.
- There is no proven infection or other obvious local pathology.
- Administer amitriptyline for treatment of PBPS.
- Offer oral pentosane polysulphate for the treatment of PBPS.
- Offer dietary advice.
- Amitriptyline has been shown to be beneficial when compared with placebo plus behavioural modification.
- The first evaluation should take place after about six weeks to determine whether the treatment has been successful.
View source ↗